It is estimated that sarcopenia is present in about 5 to 10 % of persons over 65 years of age [21], whereas the T2DM patients have two to three times higher prevalence of sarcopenia than non-diabetic individuals [22, 23] due to glucose toxicity, insulin resistance, and oxidative stress [21]. This evidence concerns the gene INS and sarcopenia.